查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1870971

凝胶柱凝集试验系统市场（依测试类型、最终用户、产品类型、应用、检体类型和血型鑑定係统划分）－全球预测，2025-2032年

Gel Column Agglutination Test system Market by Test Type, End User, Product Type, Application, Sample Type, Blood Group System - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，凝胶柱凝集试验系统市场规模将达到 58.9 亿美元，复合年增长率为 6.73%。

主要市场统计数据
基准年 2024 35亿美元
预计年份：2025年 37.3亿美元
预测年份：2032年 58.9亿美元
复合年增长率 (%) 6.73%

全面介绍凝胶柱凝集系统，说明在免疫血液学中的临床优势、工作流程整合和品质要求。

凝胶柱凝集试验系统凭藉其可重复性高、主观性低且易于自动化等优点，已从实验室的探索性技术发展成为免疫血液学和输血医学的核心技术。本次报告将概述该技术的临床目标、操作优势以及与血库、诊断实验室、医院和研究机构的重要合作。我们将阐述基于凝胶的方法如何简化输血前检测、抗体检测和表型分析的工作流程，同时减少人工操作和变异性，这在高通量、安全至关重要的环境中尤其重要。

自动化、试剂进步和监管重点正在重塑免疫血液学和输血服务的工作流程和采购重点。

自动化、试剂创新和不断发展的临床工作流程正在改变凝胶柱凝集系统的模式。自动化和半自动化系统的进步降低了操作者差异并提高了通量，而改进的试剂卡和增强的凝胶基质则提高了分析灵敏度和稳定性。因此，实验室能够提供更一致的抗体筛检和鑑定结果，从​​而促进更安全的输血操作和可靠的血清学监测。

2025年关税调整对诊断耗材和自动化免疫血液学系统的筹资策略和供应链韧性的影响

2025年美国关税调整为凝胶柱凝集试验系统及其耗材的采购和供应链管理带来了新的考量。不断变化的关税环境迫使采购部门重新评估其筹资策略，更严格地审查供应商多元化、到岸成本计算和库存缓衝。为此，多个相关人员正与供应商密切合作，协商长期供应协议和紧急计画，以降低关税波动带来的风险。

深入洞察检测类型多样性、最终用户需求、产品差异、应用需求、检体处理和血型鑑定等复杂因素。

细分市场分析揭示了凝胶柱凝集试验系统在临床应用和采购模式上的多样性。按试验类型划分，市场涵盖： -抗体筛检（3细胞和2细胞组合试验）-电子和人工交叉配对试验交叉配对试验交叉配对试验-正向和反向血型鑑定-鑑定试验，包括组合鑑别和扩展表型分析。这些试验类型的差异会影响试剂配方、仪器相容性和检验管道，从而指导实验室决定是优先选择多功能平台还是专用试剂盒。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 临床实验室越来越多地采用高通量自动化凝胶柱系统，加快了血液相容性检测的速度。
  • 透过整合云端基础的实验室资讯管理系统和凝胶柱工作流程，增强数据可追溯性
  • 开发用于分散式医疗环境中照护现场血型鑑定的微流体凝胶卡平台
  • 引入人工智慧驱动的光学读数仪进行凝胶柱凝集试验，可减少人工判读错误
  • 扩展多重凝胶柱检测技术，以同时检测多种血型抗原和抗体
  • 诊断设备製造商与生技公司建立策略联盟，推动凝胶柱聚集技术创新
  • 监管协调努力正在塑造新兴经济体先进凝胶柱测试设备的市场进入

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依测试类型分類的凝胶柱凝集试验系统市场

  • 抗体筛检
    • 三板
    • 双电池板
  • 横断面研究
    • 电子交叉测试
    • 手动交叉测试
  • 血型测定
    • 前向分组
    • 反向分组
  • 鑑别
    • 扩展表型分析
    • 面板识别

9. 依最终使用者分類的凝胶柱凝集试验系统市场

  • 血库
    • 私人血库
    • 公共血库
  • 诊断实验室
    • 医院检查室
    • 参考测试室
  • 医院
    • 二级护理
    • 三级医疗
  • 研究所
    • 学术机构
    • 製药公司

第十章 凝胶柱凝集试验系统市场（依产品类型划分）

  • 消耗品
    • 凝胶柱
    • 试剂卡
  • 装置
    • 自动化系统
    • 半自动系统

第十一章 凝胶柱凝集试验系统市场（依应用领域划分）

  • 输血
    • 免疫血液学
    • 输血前检测
  • 疾病诊断
    • 自体免疫疾病
    • 感染疾病标记物
  • 研究
    • 学术研究
    • 临床试验

12. 依检体类型分類的凝胶柱凝集试验系统市场

  • 电浆
    • 冷冻血浆
    • 新鲜冷冻血浆
  • 红血球
    • 浓缩红血球
    • 洗涤过的红血球
  • 全血
    • 枸橼酸血
    • EDTA 血

13. 依血型鑑定係统分類的凝胶柱凝集试验系统市场

  • ABO
    • A
    • AB
    • B
    • O
  • Duffy
  • Kell
    • K1
    • K2
  • Kidd
  • MNS
  • Rh
    • C
    • c
    • D
    • E
    • e

14. 各地区凝胶柱凝集试验系统市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 凝胶柱凝集试验系统市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各国凝胶柱凝集试验系统市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Ortho Clinical Diagnostics Holdings plc
    • Bio-Rad Laboratories, Inc.
    • Grifols, SA
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Abbott Laboratories
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Immucor, Inc.
    • Diagast
    • Abacus Diagnostica Ltd.
Product Code: MRR-1A1A064C0523

The Gel Column Agglutination Test system Market is projected to grow by USD 5.89 billion at a CAGR of 6.73% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.50 billion
Estimated Year [2025] USD 3.73 billion
Forecast Year [2032] USD 5.89 billion
CAGR (%) 6.73%

Comprehensive orientation to gel column agglutination systems that explains clinical advantages, workflow integration, and quality imperatives for immunohematology

The gel column agglutination test system has grown from a laboratory curiosity into a core technology for immunohematology and transfusion medicine, driven by its reproducibility, reduced subjectivity, and compatibility with automation. This introduction frames the technology's clinical purpose, operational advantages, and the critical interfaces with blood banks, diagnostic laboratories, hospitals, and research institutes. It explains how gel-based methodologies streamline pretransfusion testing, antibody detection, and phenotyping workflows while reducing manual handling and variability, which is particularly consequential in high-throughput and safety-critical environments.

In practice, the system's modularity supports both high-volume automated platforms and compact semi-automated or manual formats, making it relevant across diverse institutional settings. The technology's consumable and instrument components interplay to deliver standardized reactions, and the system's tolerance for different sample types enhances its applicability. This introduction also contextualizes quality management considerations, such as traceability, lot-to-lot reagent consistency, and internal controls, which determine clinical confidence. Finally, it highlights how ongoing innovation in reagents, column matrices, and instrument software continues to expand diagnostic capabilities and laboratory efficiency, setting the stage for deeper exploration throughout this summary.

How automation, reagent advancements, and regulatory emphasis are reshaping workflows and procurement priorities across immunohematology and transfusion services

The landscape for gel column agglutination systems is experiencing transformative shifts shaped by automation, reagent innovation, and evolving clinical workflows. Advances in automated and semi-automated systems have reduced operator-dependent variability and increased throughput, while reagent card refinements and gel matrix enhancements have improved analytical sensitivity and stability. As a result, laboratories can deliver more consistent antibody screening and identification outcomes, facilitating safer transfusion practices and more reliable serological research.

Concurrent shifts in clinical practice, such as expanded pretransfusion testing protocols and heightened immunohematology complexity due to diverse patient populations, drive demand for more capable testing platforms. Regulatory emphasis on traceability and validation has pushed vendors to integrate better software controls, audit trails, and user authentication, thereby aligning laboratory practices with compliance requirements. Furthermore, integration with laboratory information systems and digital reporting tools is accelerating, enabling smoother data flow from blood banks and diagnostic labs to hospital information systems. These combined trends are reshaping procurement priorities and operational models across institutional settings.

Impacts of 2025 tariff adjustments on procurement strategies and supply chain resiliency for diagnostic consumables and automated immunohematology systems

United States tariff changes in 2025 introduced additional considerations for procurement and supply chain management of gel column agglutination test systems and their consumables. The tariff environment has prompted procurement teams to re-evaluate sourcing strategies, with increased scrutiny on supplier diversification, landed cost calculations, and inventory buffering. In response, several stakeholders have pursued closer collaboration with suppliers to negotiate long-term supply agreements and contingency arrangements that mitigate exposure to customs and tariff volatility.

Operational teams have adjusted purchasing cadences and validation schedules to accommodate longer lead times for critical consumables such as reagent cards and gel columns. Concurrently, manufacturers and distributors have explored alternative manufacturing footprints, nearshoring strategies, and tariff classification reviews to optimize cost structures. For end users, the primary impact has been a renewed emphasis on supply chain resilience, with institutions prioritizing validated secondary suppliers and enhanced stock management. Overall, the tariff developments of 2025 accelerated a strategic pivot toward supply chain robustness and closer vendor partnerships across the diagnostic ecosystem.

Deep segmentation-driven insights that reconcile test-type diversity, end-user requirements, product variation, application demands, sample handling, and blood group complexity

Segmentation analysis reveals the diversity of clinical use cases and procurement patterns that define gel column agglutination test system adoption. Based on Test Type, the market covers Antibody Screening with both Three-Cell Panel and Two-Cell Panel approaches, Crossmatch performed via Electronic Crossmatch and Manual Crossmatch methods, Grouping split between Forward Grouping and Reverse Grouping techniques, and Identification that includes Extended Phenotyping alongside Panel Identification. These test-type distinctions influence reagent formulation, instrument compatibility, and validation pathways, and they guide laboratory decisions on whether to prioritize versatile platforms or specialized kits.

Based on End User, the technology serves Blood Banks, Diagnostic Laboratories, Hospitals, and Research Institutes, with Blood Banks further differentiated into Private Blood Banks and Public Blood Banks, Diagnostic Laboratories encompassing Hospital Laboratories and Reference Laboratories, Hospitals spanning Secondary Care and Tertiary Care facilities, and Research Institutes including Academic Institutes and Pharmaceutical Companies. The diverse end-user landscape results in varied purchasing cycles, service expectations, and capital allocation considerations, with blood banks often favoring reliability and throughput while research entities emphasize flexibility and assay customization.

Based on Product Type, the offerings include Consumables such as Gel Columns and Reagent Cards alongside Instruments categorized as Automated Systems and Semi-Automated Systems. Consumable lifecycle, lot management, and compatibility with existing instruments drive repeat purchasing behavior, whereas instrument selection reflects anticipated testing volumes, laboratory staffing, and integration requirements. Based on Application, the primary use areas include Blood Transfusion oriented work such as Immunohematology and Pretransfusion Testing, Disease Diagnostics focused on Autoimmune Disorders and Infectious Disease Markers, and Research applications spanning Academic Research and Clinical Trials. Each application sets distinct performance and documentation expectations that shape product development and validation strategies.

Based on Sample Type, the systems accept Plasma types including Cryoprecipitate and Fresh Frozen Plasma, Red Cells such as Packed Red Cells and Washed Red Cells, and Whole Blood in formats like Citrated Blood and EDTA Blood, each carrying unique preanalytical handling and stability implications. Finally, based on Blood Group System, testing addresses ABO categories subdivided into A, AB, B, and O, Duffy, Kell with distinctions such as K1 and K2, Kidd, MNS, and Rh with subtypes including C, c, D, E, and e. Collectively, these segmentation perspectives highlight the need for flexible, validated solutions that accommodate test complexity, varied sample matrices, and diverse institutional requirements.

Regional adoption patterns highlighting how healthcare infrastructure, regulatory environments, and distribution networks drive procurement and operational priorities globally

Regional dynamics shape adoption patterns, procurement priorities, and regulatory interactions for gel column agglutination systems, creating distinct operational landscapes across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established blood services and integrated hospital systems often emphasize standardization, high-throughput automation, and interoperability with laboratory IT systems, while procurement teams focus on long-term supplier relationships and service coverage to support national transfusion networks.

Across Europe, Middle East & Africa, regulatory harmonization in parts of Europe promotes stringent validation and documentation practices, whereas countries in the Middle East and Africa present heterogeneous healthcare infrastructures that demand adaptable products and robust field support. Consequently, multi-tier product strategies that include compact semi-automated systems and resilient consumables find traction across these regions. Moving to Asia-Pacific, rapid expansion of diagnostic capacity, growing emphasis on pretransfusion safety, and diverse healthcare delivery models create strong demand for both scalable automated platforms and cost-effective reagent solutions. In all regions, distribution models, local regulatory requirements, and training capabilities influence the speed and scale of adoption, while regional health priorities and funding mechanisms continue to determine which applications receive prioritized investment.

Competitive landscape analysis illustrating how product differentiation, service models, and strategic partnerships determine long-term supplier selection and customer retention

Competitive dynamics in the gel column agglutination space reflect a balance between established diagnostic players, specialized reagent manufacturers, and emerging automation-focused entrants. Leading instrument providers compete on ease of integration, software robustness, and service networks, while consumable manufacturers differentiate through reagent stability, sensitivity, and lot consistency. Strategic partnerships between reagent specialists and instrument OEMs are increasingly common, aligning product roadmaps with laboratory needs for validated, end-to-end solutions.

In addition, some companies pursue modular portfolios that support both high-volume automated laboratories and lower-volume settings, thereby widening addressable end-user segments. Others emphasize value-added services such as on-site validation support, customized training programs, and rapid replacement logistics to strengthen customer loyalty. Investment in R&D continues to center on reagent chemistry, gel matrix optimization, and digital reporting features that facilitate interpretation and regulatory compliance. Collectively, these competitive approaches shape procurement conversations and influence which suppliers are selected for long-term partnerships.

Actionable guidance for leaders to reinforce supply chains, innovate reagent and instrument capabilities, and elevate customer engagement to secure competitive advantage

Industry leaders should prioritize a combination of strategic supply chain actions, product development focus, and customer engagement practices to maintain advantage in a changing environment. First, strengthening supplier diversification and inventory orchestration will mitigate exposure to tariff volatility and shipping disruptions, while near-term contractual agreements with multiple validated suppliers will preserve operational continuity. Second, accelerating development of reagent robustness, extended shelf-life formulations, and gel matrix enhancements will address laboratory demands for reduced waste and more predictable performance.

Simultaneously, companies should invest in instrument interoperability, intuitive software, and secure data exchange capabilities to meet hospital and laboratory expectations for integration and compliance. Enhancing service models through remote diagnostics, virtual training, and outcome-focused validation packages will deepen customer relationships and reduce downtime. For procurement decision-makers, establishing cross-functional evaluation teams that include clinical scientists, laboratory managers, and IT leads will ensure that purchases align with workflow realities and regulatory responsibilities. Finally, proactive engagement with regional distributors and regulatory bodies will expedite market entry and sustain adoption across varied healthcare environments.

Methodological overview describing stakeholder engagement, technical literature synthesis, and triangulation approaches used to produce operationally relevant insights

This research synthesizes primary interviews, targeted vendor briefings, and a rigorous review of technical and regulatory literature to assemble actionable insights on gel column agglutination systems. Stakeholder inputs included clinical laboratory directors, transfusion service physicians, procurement specialists, and validation scientists, which informed interpretations of workflow challenges, product performance, and service expectations. Vendor consultations provided visibility into instrument roadmaps, consumable innovations, and distribution strategies, while technical literature helped clarify performance characteristics of gel matrices and reagent chemistries.

Evidence was triangulated across multiple sources to ensure internal consistency and to surface practical implications for end users. Where appropriate, methodology emphasized reproducibility by cross-checking claims against clinical practice guidelines, device manuals, and peer-reviewed findings on serological performance. The approach prioritized operational relevance, focusing on aspects such as ease of integration, validation burden, reagent handling, and training requirements that directly influence adoption. Limitations related to proprietary performance data and rapidly evolving product features were mitigated through follow-up vendor validation and targeted expert review to ensure conclusions remain robust and actionable.

Synthesis of core findings that link technological strengths, operational priorities, and strategic supplier engagement to enhance transfusion safety and diagnostic workflows

In conclusion, gel column agglutination systems represent a mature yet evolving technology that continues to address core challenges in immunohematology by improving reproducibility, reducing subjectivity, and supporting automation. The interplay between consumables and instruments determines clinical utility, and the need for validated, interoperable solutions grows as laboratories scale testing volumes and integrate with broader hospital IT ecosystems. Recent supply chain pressures and regulatory emphasis have further elevated the importance of supplier reliability and product documentation, requiring both vendors and end users to adapt procurement and operational practices.

Looking ahead, incremental innovations in reagent chemistry, gel formulations, and software integration will continue to shape laboratory workflows and influence adoption across blood banks, diagnostic laboratories, hospitals, and research institutes. For decision-makers, the priority is to align technology selection with clinical workflows, validation capacity, and regional regulatory expectations, while maintaining supply chain resilience. When these elements are coordinated, organizations can enhance transfusion safety, streamline diagnostic processes, and ensure that investments yield measurable operational improvements.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of high-throughput automated gel column systems in clinical laboratories to accelerate blood compatibility testing
  • 5.2. Integration of cloud-based laboratory information management systems with gel column workflows for enhanced data traceability
  • 5.3. Development of microfluidic gel card platforms enabling point-of-care blood grouping diagnostics in decentralized healthcare settings
  • 5.4. Implementation of AI-driven optical readers for gel column agglutination assays to reduce manual interpretation errors
  • 5.5. Expansion of multiplexed gel column tests for simultaneous detection of multiple blood group antigens and antibodies
  • 5.6. Strategic collaborations between diagnostic firms and biotech companies driving innovation in gel column agglutination technologies
  • 5.7. Regulatory harmonization efforts shaping market access for advanced gel column testing devices across emerging economies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gel Column Agglutination Test system Market, by Test Type

  • 8.1. Antibody Screening
    • 8.1.1. Three-Cell Panel
    • 8.1.2. Two-Cell Panel
  • 8.2. Crossmatch
    • 8.2.1. Electronic Crossmatch
    • 8.2.2. Manual Crossmatch
  • 8.3. Grouping
    • 8.3.1. Forward Grouping
    • 8.3.2. Reverse Grouping
  • 8.4. Identification
    • 8.4.1. Extended Phenotyping
    • 8.4.2. Panel Identification

9. Gel Column Agglutination Test system Market, by End User

  • 9.1. Blood Banks
    • 9.1.1. Private Blood Banks
    • 9.1.2. Public Blood Banks
  • 9.2. Diagnostic Laboratories
    • 9.2.1. Hospital Laboratories
    • 9.2.2. Reference Laboratories
  • 9.3. Hospitals
    • 9.3.1. Secondary Care
    • 9.3.2. Tertiary Care
  • 9.4. Research Institutes
    • 9.4.1. Academic Institutes
    • 9.4.2. Pharmaceutical Companies

10. Gel Column Agglutination Test system Market, by Product Type

  • 10.1. Consumables
    • 10.1.1. Gel Columns
    • 10.1.2. Reagent Cards
  • 10.2. Instruments
    • 10.2.1. Automated Systems
    • 10.2.2. Semi-Automated Systems

11. Gel Column Agglutination Test system Market, by Application

  • 11.1. Blood Transfusion
    • 11.1.1. Immunohematology
    • 11.1.2. Pretransfusion Testing
  • 11.2. Disease Diagnostics
    • 11.2.1. Autoimmune Disorders
    • 11.2.2. Infectious Disease Markers
  • 11.3. Research
    • 11.3.1. Academic Research
    • 11.3.2. Clinical Trials

12. Gel Column Agglutination Test system Market, by Sample Type

  • 12.1. Plasma
    • 12.1.1. Cryoprecipitate
    • 12.1.2. Fresh Frozen Plasma
  • 12.2. Red Cells
    • 12.2.1. Packed Red Cells
    • 12.2.2. Washed Red Cells
  • 12.3. Whole Blood
    • 12.3.1. Citrated Blood
    • 12.3.2. EDTA Blood

13. Gel Column Agglutination Test system Market, by Blood Group System

  • 13.1. ABO
    • 13.1.1. A
    • 13.1.2. AB
    • 13.1.3. B
    • 13.1.4. O
  • 13.2. Duffy
  • 13.3. Kell
    • 13.3.1. K1
    • 13.3.2. K2
  • 13.4. Kidd
  • 13.5. MNS
  • 13.6. Rh
    • 13.6.1. C
    • 13.6.2. c
    • 13.6.3. D
    • 13.6.4. E
    • 13.6.5. e

14. Gel Column Agglutination Test system Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Gel Column Agglutination Test system Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Gel Column Agglutination Test system Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Ortho Clinical Diagnostics Holdings plc
    • 17.3.2. Bio-Rad Laboratories, Inc.
    • 17.3.3. Grifols, S.A.
    • 17.3.4. Thermo Fisher Scientific Inc.
    • 17.3.5. Danaher Corporation
    • 17.3.6. Abbott Laboratories
    • 17.3.7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 17.3.8. Immucor, Inc.
    • 17.3.9. Diagast
    • 17.3.10. Abacus Diagnostica Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD GROUP SYSTEM, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD GROUP SYSTEM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY THREE-CELL PANEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY THREE-CELL PANEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY THREE-CELL PANEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY THREE-CELL PANEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY THREE-CELL PANEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY THREE-CELL PANEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TWO-CELL PANEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TWO-CELL PANEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TWO-CELL PANEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TWO-CELL PANEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TWO-CELL PANEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TWO-CELL PANEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ELECTRONIC CROSSMATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ELECTRONIC CROSSMATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ELECTRONIC CROSSMATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ELECTRONIC CROSSMATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ELECTRONIC CROSSMATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ELECTRONIC CROSSMATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY MANUAL CROSSMATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY MANUAL CROSSMATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY MANUAL CROSSMATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY MANUAL CROSSMATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY MANUAL CROSSMATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY MANUAL CROSSMATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY FORWARD GROUPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY FORWARD GROUPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY FORWARD GROUPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY FORWARD GROUPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY FORWARD GROUPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY FORWARD GROUPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REVERSE GROUPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REVERSE GROUPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REVERSE GROUPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REVERSE GROUPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REVERSE GROUPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REVERSE GROUPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY EXTENDED PHENOTYPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY EXTENDED PHENOTYPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY EXTENDED PHENOTYPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY EXTENDED PHENOTYPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY EXTENDED PHENOTYPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY EXTENDED PHENOTYPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PANEL IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PANEL IDENTIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PANEL IDENTIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PANEL IDENTIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PANEL IDENTIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PANEL IDENTIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRIVATE BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRIVATE BLOOD BANKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRIVATE BLOOD BANKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRIVATE BLOOD BANKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRIVATE BLOOD BANKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRIVATE BLOOD BANKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PUBLIC BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PUBLIC BLOOD BANKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PUBLIC BLOOD BANKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PUBLIC BLOOD BANKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PUBLIC BLOOD BANKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PUBLIC BLOOD BANKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SECONDARY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SECONDARY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SECONDARY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SECONDARY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SECONDARY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SECONDARY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TERTIARY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GEL COLUMNS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GEL COLUMNS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GEL COLUMNS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GEL COLUMNS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GEL COLUMNS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GEL COLUMNS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REAGENT CARDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REAGENT CARDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REAGENT CARDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REAGENT CARDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REAGENT CARDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REAGENT CARDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SEMI-AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SEMI-AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SEMI-AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SEMI-AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SEMI-AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SEMI-AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IMMUNOHEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IMMUNOHEMATOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IMMUNOHEMATOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IMMUNOHEMATOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IMMUNOHEMATOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IMMUNOHEMATOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRETRANSFUSION TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRETRANSFUSION TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRETRANSFUSION TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRETRANSFUSION TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRETRANSFUSION TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRETRANSFUSION TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE MARKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE MARKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE MARKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE MARKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE MARKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE MARKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL GEL COLUMN AGGLUT